The Library
Association of cortical and subcortical microstructure with clinical progression and fluid biomarkers in patients with Parkinson Disease
Tools
Wang, Linbo, Zhou, Cheng, Zhang, Wei, Zhang, Minming, Cheng, Wei and Feng, Jianfeng (2023) Association of cortical and subcortical microstructure with clinical progression and fluid biomarkers in patients with Parkinson Disease. Neurology, 101 (3). e300-e310. doi:10.1212/WNL.0000000000207408 ISSN 0028-3878.
Research output not available from this repository.
Request-a-Copy directly from author or use local Library Get it For Me service.
Official URL: https://doi.org/10.1212/WNL.0000000000207408
Abstract
Mean diffusivity (MD) of diffusion magnetic resonance imaging (dMRI) has been used to measure cortical and subcortical microstructural properties. This study investigated relationships of cortical and subcortical MD, clinical progression and fluid biomarkers in Parkinson disease (PD). This longitudinal study using data from the Parkinson's progression markers initiative (PPMI) were collected from April, 2011, to July, 2022. Clinical symptoms were assessed with MDS-UPDRS and MoCA scores. Clinical assessments were followed up to five years. Linear mixed-effects (LME) models were performed to examine associations of MD and annual rate of changes in clinical scores. Partial correlation analysis was conducted to examine the associations of MD and fluid biomarker levels. A total of 174 PD patients (age 61.9 ± 9.7, 63% male) with baseline dMRI and at least two years clinical follow-up were included. Results of LME models revealed significant association between MD values, predominantly in subcortical regions, temporal lobe, occipital lobe and frontal lobe, and annual rate of changes in clinical scores (MDS-UPDRS-Part-I, standardized β > 2.35; MDS-UPDRS-Part-II, standardized β > 2.34; PIGD score, standardized β > 2.47; MoCA, standardized β < -2.42; all < 0.05, FDR corrected). In addition, MD was associated with the levels of neurofilament light chain (NfL) in serum ( > 0.22) and α-synuclein (right putamen = 0.31), Amyloid-β 1 to 42 (Aβ ) (left hippocampus = -0.30), phosphorylated tau at 181 threonine position (P-tau) ( > 0.26) and total tau (T-tau) ( > 0.23) in cerebrospinal fluid (CSF) at baseline (all < 0.05, FDR corrected). Furthermore, the β coefficients derived from MD and annual rate of changes in clinical score recapitulated the spatial distribution of dopamine (DAT, D1 and D2), glutamate (mGluR5 and NMDA), serotonin (5-HT1a and 5-HT2a), cannabinoid (CB1) and GABAneurotransmitter receptors/transporters ( < 0.05, FDR corrected) derived from positron emission tomography scans in the brain of healthy volunteers. In this cohort study, cortical and subcortical MD values at baseline were associated with clinical progression and baseline fluid biomarkers, suggesting microstructural properties could be useful for stratification of patients with fast clinical progression. [Abstract copyright: © 2023 American Academy of Neurology.]
Item Type: | Journal Article | ||||||||
---|---|---|---|---|---|---|---|---|---|
Divisions: | Faculty of Science, Engineering and Medicine > Science > Computer Science | ||||||||
SWORD Depositor: | Library Publications Router | ||||||||
Journal or Publication Title: | Neurology | ||||||||
Publisher: | Lippincott Williams & Wilkins | ||||||||
ISSN: | 0028-3878 | ||||||||
Official Date: | 18 July 2023 | ||||||||
Dates: |
|
||||||||
Volume: | 101 | ||||||||
Number: | 3 | ||||||||
Page Range: | e300-e310 | ||||||||
DOI: | 10.1212/WNL.0000000000207408 | ||||||||
Status: | Peer Reviewed | ||||||||
Publication Status: | Published | ||||||||
Access rights to Published version: | Restricted or Subscription Access | ||||||||
Copyright Holders: | © 2023 American Academy of Neurology |
Request changes or add full text files to a record
Repository staff actions (login required)
View Item |